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Summary The hypoxic toxicity and binding of misonidazole (MISO) requires metabolic reduction. The
influence of glucose on the toxicity and binding of MISO was studied because glucose is a major substrate for
the supply of NADPH through the hexose menophosphate pathway (HMP). Hypoxic EMT6/Ro cells
(106 cellsml-) were incubated with varying concentrations of glucose (0.015mm to 5mM). The initial rate of
glucose transport was found to increase linearly with the extracellular glucose concentration up to 5 mM
(0.038nmol glucose 10-6cellssec'1). About 1.5 percent of the total glucose consumed went through the HMP
for hypoxic cells in 5mm glucose. The rate of HMP progressively decreased as the glucose concentration was
lowered. When exposed to 5mm MISO, the HMP was stimulated. This stimulation declined from 3.2 times in
5 mm glucose to barely detectable below 1 mM glucose. Both the hypoxic toxicity and binding of 5 mM MISO
to the acid-insoluble fraction were decreased as the concentration of glucose was lowered. Below 0.5 mM
glucose, no significant toxicity due to MISO was observed. There was an initial burden of 2.5nmol
MISO 10'6 cells bound with little toxicity. After this intial burden, the terminal slope was 1.8mol MISO
bound 1o-6 cells (63 percent decrease in the surviving fraction). These results indicate that glucose
concentrations lower than 5 mm can decrease the HMP rate and the toxicity and binding of MISO to hypoxic
cells, and imply that calibration curves with normal and low glucose concentrations should be used to
estimate the possible hypoxic fraction when MISO is used as a hypoxic probe in vivo.
The selective cytoxicity of misonidazole (MISO)
towards hypoxic cells has been well established
(Moore et al., 1976; Mohindra & Rauth, 1976;
Sutherland et al., 1980). Similarly, the binding of
MISO with regard to oxygen dependence has been
well documented (Miller et al., 1982; Chapman et
al., 1983; Koch et al., 1984). Other biochemical
atlerations such as inhibitions of glucose
consumption, lactate formation (Varnes & Biaglow,
1984; Ling & Sutherland, 1986a) and DNA
synthesis (Olive, 1979) have also been observed
upon incubation of hypoxic mammalian cells with
MISO. Metabolic reduction of MISO is considered
to be necessary for these biochemical alterations
(Chapman et al., 1981; Raleigh et al., 1981; Olive,
1980; McCalla et al., 1970; Varghese et al., 1976).
Under hypoxic conditions, MISO is postulated to
be metabolically reduced to intermediates capable
of binding with a variety of intracellular molecules
(Varghese & Whitmore, 1980). The kinetic depen-
dence on oxygen concentration for the toxicity and
binding of MISO for several cell lines has been
reported (Koch et al., 1984; Mulcahy, 1984).
However, successful metabolic reduction requires
not only the necessary enzymes and the absence of
oxygen which would reverse reduction, but also
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substrates to supply reducing equivalents. In most
mammalian cells, the hexose monophosphate
pathway (HMP) is the major pathway for the
supply of reducing equivalents. Glucose is its initial
substrate. Concentrations of oxygen and glucose
are known to vary among tumours (Thomlinson &
Gray, 1955; Tannock, 1968; Streffer et al., 1980).
Drugs such as MISO are being investigated for
potential therapeutic purposes to overcome the
resistance of hypoxic cells to radiation and chemo-
therapy. Their preferential binding to hypoxic cells
may also be useful in locating areas of hypoxia in
the body. However for such utilization, it is
important that this preferential toxicity and binding
to hypoxic cells are independent of factors other
than oxygen. It is therefore important to examine
the effect of glucose concentration on the toxicity
and binding of MISO under hypoxic conditions.
Materials and methods
(a) Culture ofthe cells
EMT6/Ro cells were maintained as monolayers in
continuous exponential growth in BME, (Eagles
Basal Medium, Grand Island Biological Co.
NY) supplemented with 15% foetal calf serum
(Flow Laboratories Inc., MacLean VA), 4.7 x
10-2 mgml- ' glutamine (Gibco, Grand Island
Co., NY), 960mgml1 streptomycin, 96 units ml-
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penicillin. The cells were grown in a humidified
incubator at 37°C in an atmosphere of 3%
C02/97% air. The cells were subcultured twice
weekly by dissociation with 0.01% lypophilized
trypsin (Worthington Biochemical Corp., Freehold,
NJ) in sodium citrate buffer, pH7.2 and routinely
checked for mycoplasma contamination.
For these studies, exponential cell cultures were
dissociated with 0.01% trypsin for 10min and
concentrated to 106cellsml-1 in BME media with
different concentrations of glucose. The cells and
MISO were continuously gassed separately with 3%
CO2 in nitrogen for 1.5h at 37°C in glass vials with
continuous gentle stirring. After hypoxia of less
than 100ppm oxygen was induced (Mulcahy, 1984),
hypoxic MISO was added to the cell suspension. At
different times, the following measurements were
made.
(b) Survival
Survival was determined by the colony forming
assay. The cells were seeded into triplicate plastic
cultures dishes at concentrations to give 50
colonies. Normally, triplicates of two dilutions were
set for each experimental point determined. After
11 days the plates were stained with methylene blue
and colonies of greater than 50 cells were scored.
(c) Hexose monophosphate pathway
Hexose monophosphate pathway (HMP) activity
was determined by the release of 14CO2 from C-1
glucose (Cuppy & Crevasse, 1963; Katz & Wood,
1960). One pCi of the labelled glucose was added
for every 10ml of media. After hypoxia of less than
100ppm oxygen was achieved, hypoxic cells were
added to the media and the vials tightly sealed. At
different times, 14CO2 was released from the cell
suspension by acidification with 0.2ml 6NHCl. Air
was flushed through the vial into 1M KOH.
Constant flushing with serial tubes of 1 M KOH for
different times, and the capacity to quantitatively
account for all the radioactivity added at the end of
the experiment determine that complete trapping of
14CO2 is accomplished within 0.5 h of flushing.
After flushing for 0.5h, an aliquot (1 ml) of the
KOH was counted in 10ml of scintillation fluid
(Scintiverse, Fischer Company, USA), to determine
the amount of 14CO2 trapped in it.
(d) Binding of 14C-MISO
Binding of 14C-MISO (labelled at C-2 of the
imidazole ring) to cells was determined by adding
14C-MISO to a final concentration of 5mm (specific
activity 0.2mCimmol-1). After different times of
incubation, 1 ml of the cell suspension was removed
and spun down. The pellet was washed with 1 ml of
ice cold saline solution before resuspension in 1 ml
of ice-cold 10% trichloroacetic acid (TCA). After
10min, the TCA precipitate was washed once with
1 ml of ice cold 10% TCA and then counted in
5 ml of scintillation fluid (Scintiverse, Fisher
Company, USA).
(e) Glucose transport
Glucose transport was measured with the D-glucose
analog, 3-0-methyl-D-glucose (3-OMG), which is
transported into the cells in the same way as D-
glucose (Graff et al., 1978; Weber, 1973). The cells
were incubated in normal growth media and [14C]-
3-0-methyl-D-glucose (0.3,iCiml-1, Amersham;
120pCirmmol-1) for various lengths of time and
rapidly separated from their radioactive media by
spinning through a mixture of n-butyl-
phthalate:Mazola corn oil (4:1 mixture). The cell
pellets were then dried and counted. Incubations
were carried out at 15sec intervals up to a minute
to obtain an initial rate of uptake.
Results
The intracellular concentration of glucose could
limit processes that need glucose in the cells. In
EMT6/Ro cells, glucose had been shown to be
transported via a facilitated diffusion that is both
selective and phloretin-sensitive (Ling & Sutherland,
1986a). When the glucose analog, 3-0-methyl-D-
glucose, is used in such transport experiments, an
equilibrium of intracellular concentration equivalent
to the extracellular concentration is achieved within
a minute. Figure 1 shows that this transport of
glucose is also dependent on the glucose concen-
trations in EMT6/Ro cells. Similar results are
observed for both aerobic and acutely hypoxic
EMT6/Ro cells. The initial rates of glucose uptake
depend on the extracellular concentration of
glucose and increased linearly with glucose
concentration up to 5mm glucose. Increasing the
concentration 5-fold to 25mm glucose did not
further increase the rate of uptake. Thus the rates
of activity of glucose metabolic pathways which
could affect the redox balance of the cells and
therefore, reductive metabolism of MISO, would be
expected to vary significantly over the range of 0 to
5mm glucose.
Figure 2 shows the effect of lowering glucose
over this concentration range on the hypoxic
toxicity of 5mM MISO. As the concentration of
glucose was lowered, hypoxic toxicity due to 5mm
MISO progressively lessened. This was seen
primarily as a decrease in the terminal slope of
killing after an initial latent period. The absence of
glucose was itself slightly toxic, decreasing theHYPOXIC TOXICITY AND BINDING OF MISO-GLUCOSE EFFECTS
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surviving fraction to IO0% after 2.5h of hypoxic
incubation. Below 0.5 mm glucose, no significant
toxicity due to MISO was observed.
For hypoxic EMT6/Ro cells in 5mm glucose,
- 1.5% of the total glucose was consumed through
the hexose monophosphate pathway (HMP). Figure
3 shows the rates of HMP in EMT6/Ro cells. For
cells in 5mm glucose, the rate of HMP was slightly
decreased by the absence of oxygen and stimulated
by the presence of 5mm MISO. The absolute rate
of HMP was dependent on the concentration of
glucose supplied. It progressively decreased as the
concentration ofglucose decreased.
The presence of 5 mm MISO was found to
stimulate the HMP rate in both aerobic and
hypoxic conditions. This stimulation was also
dependent on glucose concentration (Figure 4).
Under hypoxic condition, this stimulation decreased
from 3.2 times in 5mm glucose to barely detectable
in 1 mm glucose.
Figure 5 shows that the binding of 14C-MISO to
the acid-insoluble fraction in hypoxic cells was
similarly dependent on glucose concentration.
Binding was significant only in hypoxic cells. There
was an initial increase in binding before a gradual
cessation for most concentrations of glucose used.
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Figure 2 Surviving fraction of hypoxic EMT6/Ro
cells (106cellsml-1) incubated with different
concentrations of glucose and misonidazole. The data
were corrected for the plating efficiency of the cells at
the start of the experiment. Data points are the
means+s.e. of 3 separate experiments.
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Figure 3 The rates of hexose monophosphate
pathway of EMT6/Ro cells incubated with different
concentrations of glucose and 5mM misonidazole.
Data points are the means+s.e. of at least 2 separate
experiments.
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Figure 4 The stimulation of the hexose monophos-
phate pathway by 5 mm misonidazole at different con-
centrations of glucose. Data points are the means+s.e.
of at least 2 separate experiments. The statistical
significance of differences between mean values was
tested by Student's t test.
0.05<P<0.02 for 5mm glucose compared to 2.5mM
glucose
0.05<P<0.02 for 1mm glucose compared to 2.5mM
glucose
The means of 1mM, 0.5mM, and 0.015mM glucose
were not significantly different.
However, the lower the glucose concentration
during the incubation period, the slower was the
binding. The binding of MISO to cells incubated in
lower glucose concentrations also slowed down
sooner as well as at a lower magnitude of bound
MISO. Thus cells incubated with 5 mm glucose
continued to bind MISO even after 2.5 h incubation
at 9.0nmol MISO 10-6 cells whereas cells in
0.015mm glucose had already ceased to bind MISO
after 2.0h incubation at 3 nmol MISO 10-6 cells.
Figure 6 shows the correlation of the amount of
MISO bound in the acid-insoluble fraction to the
level of survival in hypoxic cells which has been
corrected for toxicity due to low concentration of
glucose. About 2.5nmol MISO 10-6 cells could be
bound before any toxicity due to MISO was seen.
After this initial burden,
- 1.5nmol MISO 10-6
cells were bound with the decrease of cell survival
down to 37%.
In other experiments performed later, the
presence of a high concentration of glucose, 25 mm,
was compared to 5 mm glucose. The absolute rate
of the HMP and its stimulation by 5 mM MISO
were similar in both 5 and 25 mm glucose. The
cytotoxic effect and binding of MISO to hypoxic
cells in 25 mm glucose were essentially identical to
those in 5 mm glucose.
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Figure 5 Binding of '4C-misonidazole to the acid-
insoluble fraction of EMT6/Ro cells incubated with
different concentrations of glucose and 5mM
misonidazole. Data points are the means+s.e. of 5
separate experiments.
Discussion
Misonidazole, an electron-affinic nitroimidazole, is
preferentially toxic to hypoxic cells (Moore, et al.,
1976; Mohindra & Rauth, 1976; Sutherland et al.,
1980). Under hypoxic conditions, MISO also causes
a series of biochemical alterations such as inhibition
of DNA synthesis (Olive, 1980), and impairment of
glycolysis (Varnes & Biaglow, 1982; Ling &
Sutherland, 1986a). The biochemical atlerations
were known to be enhanced when the cells were
deprived of oxygen. It was generally considered
that the metabolic reduction of MISO was
necessary for these effects. However, the absence of
oxygen is not the only important consideration for
bioreductive metabolism. In most mammalian cells,
the hexose monophosphate pathway (HMP) is the
major pathway involved in reductive metabolism.
Glucose is the initial substrate for the supply of
reducing equivalents through HMP. This study
examined the importance of glucose concentration
for the mechanism of cytotixicity of MISO under
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Figure 6 Amount of 14C-misonidazole bound to the
acid-insoluble fraction of EMT6/Ro cells at different
surviving fractions, after the same duration of
incubation in misonidazole.
conditions where oxygen was not present to reverse
reductive metabolism.
Conditions were kept constant throughout the
incubation as it was known that changes e.g. in cell
density could modify the hypoxic toxicity of MISO
(Olive, 1981; Ling & Sutherland, 1986a). The
parameters measured here were the cytotoxicity of
MISO, the rate of HMP, the stimulation of HMP
by MISO, the binding of MISO to the acid-
insoluble fraction as well as the initial rates of
glucose uptake. They were all shown to increase
with the extracellular glucose concentration up to
5 mm glucose. Effects of MISO seen in cells
incubated in 5mm glucose were essentially identical
to those in 25 mm glucose.
When hypoxic cells were incubated in 5 mM
glucose, the HMP accounted for 1.5% of the total
amount of glucose consumed which is
12.3+1.lnmol glucosel -6 cellsmin-t (Ling &
Sutherland, 1986a). The rate of HMP was a
measure of the extent of redutive metabolism in the
cells. The HMP had been shown to increase in the
presence of MISO (Varnes et al., 1984). This
stimulation of HMP represented the extra demand
in reductive metabolism due to the presence of
5mM MISO. Both the rate of HMP and its
stimulation by MISO in hypoxic cells were
dependent on the extracellular glucose concen-
tration. From 5mm to 0.015mm glucose, there was
a four order of magnitude decrease in HMP
activity. The stimulation of HMP by MISO also
dropped from 3.2 times in 5mm glucose to almost
undetectable below 1 mm glucose. This indicated
that when glucose was plentiful and the HMP rate
was high, MISO could still stimulate the HMP to
an even higher rate. However at low concentration
of glucose MISO failed to stimulate the rate of
HMP because glucose itself became a limiting
factor for the rate of the HMP.
It is really the intracellular concentration of
glucose that could limit processes in the cells that
need glucose. In EMT6/Ro cells, as in most mam-
malian cells, glucose is transported via facilitated
diffusion (Graff et al., 1978; Weber, 1973), which
had been shown to be selective and phloretin-
sensitive (Ling & Sutherland, 1986a). As shown in
Figure 1, the initial rate of this transport in
EMT6/Ro cells was also directly dependent on the
extracellular concentration up to 5mm glucose.
Therefore the transport of glucose into cells may
restrict the extent of reductive metabolism by
limiting the concentration of its initial substrate,
intracellular glucose.
There was no significant difference between the
plating efficiency of hypoxic cells in glucose
concentration from 0.5mm to 5mm during the time
course of the incubation (unpublished
observations). Only an extremely low concentration
of glucose (0.015mM) was toxic to hypoxic cells.
The toxicity of 5mM MISO to hypoxic cells was
decreased by lowering the glucose concentration.
There was a decrease in the plating efficiency after
an initial latent period. However, for cells
incubated in glucose concentrations less than 1 mm,
and 5mM MISO, the decline in plating efficiency
gradually decreased. This may reflect the con-
tinuous utilization of glucose. The gradual decrease
of plating efficiency with time may indicate that
glucose had been depleted to the level below which
it limited the process(es) responsible for toxicity.
The lower the initial starting glucose concentration,
the faster this limiting glucose concentration and
therefore, the loss of toxicity of MISO would be
reached.
The metabolism-induced (via reduction) binding
of MISO has been shown to be highly dependent
on oxygen and MISO concentrations (Koch et al.,916 L.L. LING & R.M. SUTHERLAND
1984; Chapman et al., 1983). The binding of MISO
to the acid-insoluble fraction of cells is of high
affinity (Ling et al., 1986b). Under our conditions,
the binding of MISO to the acid-insoluble fraction
was significant only in hypoxic cells and increased
with higher glucose concentration. As the
concentration of glucose was lowered, the initial
increases in the binding of MISO were progressively
more gradual and plateaued at earlier times as well
as at lower levels. Again this may be reflective of a
constant depletion of glucose such that the lower
the initial starting glucose concentration, the earlier
the limiting glucose concentration and thus
cessation of binding was reached. Thus, at
0.015 mm glucose, the binding of MISO has
stopped after 2.0h whereas at 5mm glucose, the
binding of MISO was still observed after 2.5h.
The cytotoxicity and the binding of MISO may
be consequences of the reductive metabolism of
MISO under hypoxic conditions. However, the
binding of MISO to the acid-insoluble fraction need
not necessarily be causally related to the hypoxic
cytotoxicity of MISO. Nevertheless, the points in
Figure 6 (amount of bound MISO relative to the
hypoxic toxicity for cells incubated for the same
duration of time and the same glucose concen-
tration) lie on a line independent of glucose concen-
tration. This implies that the amount of bound
MISO can indicate the extent of cytotoxicity.
Under our conditions, after an initial latent amount
of binding of 2.5nmol MISO 10-6 cells, the
terminal slope of the decrease in plating efficiency
was 1.8 nmol MISO bound 10-6 cells.
The use of nitroimidazoles and other drugs that
may need reductive metabolism are being clinically
assessed. These drugs have also been considered for
imaging. Preliminary studies in spheroid models
have indicated that in the inner core of the
spheroid, not only is oxygen limited but glucose
may also be depleted. Glucose may be depleted at
about the same time or perhaps even earlier than
oxygen. The data in this study indicate that for the
maximum expression of toxicity and binding of
MISO, cells have to be both hypoxic and amply
supplied with glucose. In the case of hypoxic cells
depleted of glucose, the use of high concentrations
of hypoxic probes such as MISO that requires
reductive metabolism, could underestimate the
hypoxic fraction unless calibration curves in the
appropriate glucose concentration are used. It may
also be possible to enhance the hypoxic toxicity and
binding of MISO in vivo by increasing glucose
supply should one suspect the inner core of a
tumour to be depleted of glucose. This study
indicates the necessity of considering the involve-
ment of glucose when considering the use of MISO
or other drugs that require reductive metabolism
for hypoxic cytotoxicity or imaging.
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